Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

por Arbyn, M, Kyrgiou, M, Simoens, C, Raifu, A O, Koliopoulos, G, Martin-Hirsch, P, Prendiville, W, Paraskevaidis, E
Publicado 2008

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation

por Minas, V, Rolaki, A, Kalantaridou, S N, Sidiropoulos, J, Mitrou, S, Petsas, G, Jeschke, U, Paraskevaidis, E A, Fountzilas, G, Chrousos, G P, Pavlidis, N, Makrigiannakis, A
Publicado 2007

Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature

por Kalliala, I., Athanasiou, A., Veroniki, A.A., Salanti, G., Efthimiou, O., Raftis, N., Bowden, S., Paraskevaidi, M., Aro, K., Arbyn, M., Bennett, P., Nieminen, P., Paraskevaidis, E., Kyrgiou, M.
Publicado 2020

Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity

por Mitra, A., MacIntyre, D. A., Lee, Y. S., Smith, A., Marchesi, J. R., Lehne, B., Bhatia, R., Lyons, D., Paraskevaidis, E., Li, J. V., Holmes, E., Nicholson, J. K., Bennett, P. R., Kyrgiou, M.
Publicado 2015